-
Top-seeded Zverev opens US Open campaign
-
Heavy rain at Grand Canyon after flood kills 2, dozen missing
-
US regulator, 22 states accuse Amazon of 'manipulating' ad auctions: lawsuit
-
Kushner blames soccer power struggle for World Cup plan collapse
-
TRON Founder Justin Sun Shares Outlook on Bitcoin, Stablecoins and Global Finance at Bitcoin Asia 2026
-
Buoyant Alcaraz shakes off nerves to advance at US Open
-
Tributes to 'eternal' Messi on Argentina retirement
-
US draws European pushback with Russia G20 finance invite
-
Arteta hails Arsenal's 'finishers' after Saka kills off Villa
-
Jury begins deliberations in Tupac Shakur murder trial
-
Yamal, Raphinha bag braces as Barcelona rout Rayo
-
US Supreme Court allows Trump ballroom project to proceed
-
Alcaraz makes winning return at US Open, Sabalenka safely through
-
Trump says US reviewing position on Falkland Islands
-
Everton agree to sign Monaco's Balogun: reports
-
Saka strikes as flawless Arsenal punish troubled Villa
-
Milei calls for F1 to return to Argentina
-
Oil prices surge on renewed fighting in US-Iran war
-
Alcaraz wins US Open first-round match after injury layoff
-
Cycling superstar Pogacar has surgery after Vuelta crash
-
Kyiv orders heightened security amid intense Russian drone strikes
-
Man City agree deal for Everton's Ndiaye
-
Sabalenka kickstarts US Open three-peat bid as Fils crashes out
-
Apple CEO Tim Cook gives nod to founder Steve Jobs in final memo
-
Fils upset by resurgent Tsitsipas at US Open
-
Russian finance minister makes unexpected appearance at G20
-
Trump says AI data center opponents want to be 'backwards and poor'
-
Happy to be back in NY, Sabalenka advances
-
Pakistan ditch coaches, send seven players home after England defeats
-
Naomi Watts to receive lifetime award at top Spain film fest
-
Galliano pulls Met Gala exhibit after antisemitism backlash
-
Jury hears closing arguments in Tupac Shakur murder trial
-
Afghan people should 'not be abandoned': top Red Cross official
-
Pakistan sack coach, send seven players home after England defeats
-
Six defining moments of Lionel Messi's Argentina career
-
New storms threaten Grand Canyon flood search, 2 bodies recovered
-
Trump blasts US backlash against data centers
-
France takes aim at ultra-fast fashion with new levy
-
It 'hurts' says Messi of decision to retire from international football
-
Tribunal says India cannot withdraw from water treaty with Pakistan
-
Benzema ends brief stint with Al Hilal in Saudi league
-
John Galliano pulls US exhibition after antisemitism backlash
-
Djokovic's Grand Slam future uncertain after brutal US Open defeat
-
French Top 14 boss offers 'no guarantees' for first Club World Cup
-
Turkey says regional defence pact not against any country
-
Munoz reunites with Glasner after joining Forest from Palace
-
US vows to keep economic pressure on Iran as G20 finance talks begin
-
Liverpool sign Barcola from PSG for £124 million
-
Shein valued at $26.3 bn in Hong Kong market debut
-
Putin, Xi hold talks in Kyrgyzstan as regional summit begins
Evolution Devices Announces First Multi-Location Clinical Sale of EvoWalk to Leading Rehabilitation Provider, Advancing National Commercialization
SAN FRANCISCO, CA / ACCESS Newswire / May 12, 2026 / Evolution Devices today announced its first multi-location clinical sale of EvoWalk to Sheltering Arms Institute, a globally recognized leader in physical rehabilitation. The deployment marks a key milestone in Evolution Devices' commercial expansion and underscores growing demand for next-generation mobility solutions in neurorehabilitation.
EvoWalk Device is Worn Just Below the Knee
EvoWalk is designed to improve gait and restore functional walking in individuals with neurological impairments. The system delivers multi-muscle stimulation to enable a more coordinated, natural walking pattern across clinical and home environments, while AI-driven data capture monitors patient progress, adherence, and outcomes to inform clinical decision-making and personalize care.
"The EvoWalk represents a meaningful advancement over our current functional electrical stimulation (FES) systems," said Christina Withers, P.T., D.P.T., P.C.S., senior manager of outpatient therapy services at Sheltering Arms Institute. "Its intuitive design streamlines setup, allowing clinicians to focus more time on patient care and outcomes, while reusable leads and electrodes eliminate per-patient supply costs and improve efficiency."
"The EvoWalk has been a valuable addition for our patient population," said Zach Crump, P.T., D.P.T., N.C.S., locomotor specialist and clinical researcher at Sheltering Arms Institute. "Rapid setup and Bluetooth connectivity improve therapist efficiency, while targeted stimulation for up to six muscle groups supports more effective gait training. Integrated metrics such as step count, gait speed, and cadence provide actionable insights to guide progress."
"This first multi-site clinical sale validates both EvoWalk and the broader need for more effective mobility solutions," said Pierluigi Mantovani, chief executive officer of Evolution Devices. "We are proud to partner with Sheltering Arms Institute, a global leader in neurorehabilitation, as we take the next step toward national commercialization and expanded patient access."
Evolution Devices plans to expand through additional clinical partnerships, broader market access, and continued investment in data-driven insights to support adoption across rehabilitation settings.
About EVOLUTION DEVICES
Evolution Devices is a neurotechnology company advancing mobility solutions for the millions of individuals living with neurological impairments. The company develops innovative, clinically grounded devices designed to restore functional movement, improve gait, and enable greater independence in real-world settings. Evolution Devices' mission is to create accessible and innovative technology to enable anyone, anywhere to receive personalized rehabilitative care, empowering their independence through access to innovative care. For more information, visit www.evolutiondevices.com.
About EVOWALK
EvoWalk is a neurotechnology solution designed to improve gait and restore functional walking for individuals with neurological impairments. Addressing foot drop in addition to calf weakness, knee hyperextension, and hip weakness, it enables a more natural, stable walking pattern in real-world settings. EvoWalk integrates adaptive stimulation with AI-driven data capture to monitor patient progress, adherence, and outcomes - providing actionable insights for clinicians. Lightweight and user-friendly, it supports consistent use and scalable deployment across home and healthcare environments.
Images and Video: LINK
Media Contact
Erica Zeidenberg
Hot Tomato Marketing
925.518.8159
[email protected]
SOURCE: Evolution Devices
View the original press release on ACCESS Newswire
L.Miller--AMWN
